Page last updated: 2024-08-21

nicotinamide mononucleotide and Obesity

nicotinamide mononucleotide has been researched along with Obesity in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (30.00)24.3611
2020's7 (70.00)2.80

Authors

AuthorsStudies
Chen, Y; Dai, X; Guo, F; Han, Z; Li, L; Li, Z; Wang, L; Wang, Z; Wei, J; Zhang, X; Zhu, H1
Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE1
Apte, RS; Bhargava, A; Bhasin, S; Cheng, M; Ghattas-Puylara, C; Latham, N; Lavu, S; Lawney, B; Lin, AP; Livingston, D; Memish-Beleva, Y; Merugumala, S; Orkaby, AR; Ozimek, NE; Pencina, KM; Reid, KF; Sinclair, DA; Storer, T; Swain, PM; Valderrabano, R; Wilson, L; Wipper, B1
Tian, D; Wang, H; Wang, M; Xi, P; Zhang, Y; Zhu, W1
Craighead, DH; Freeberg, KA; Martens, CR; Seals, DR; Udovich, CC1
Chowdhury, SS; Hagan, C; Morris, MJ; Sinclair, DA; Uddin, GM; Youngson, NA1
Franczyk, MP; Imai, SI; Kayser, BD; Klein, S; Mills, KF; Patterson, BW; Patti, GJ; Pietka, T; Sindelar, M; Yoshino, J; Yoshino, M1
Chowdhury, S; Haque, S; Mehedi, I; Nahid, NA; Poddar, SK; Sifat, AE1
Borradaile, NM; Chan, P; Hughes-Large, JM; Pang, DK; Robson, DL; Toma, J1
Franczyk, MP; Imai, S; Kelly, SC; Moseley, AC; Qi, N; Stromsdorfer, KL; Yamaguchi, S; Yoon, MJ; Yoshino, J1

Reviews

2 review(s) available for nicotinamide mononucleotide and Obesity

ArticleYear
Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2023, Dec-01, Volume: 78, Issue:12

    Topics: Aged; Aging; Dietary Supplements; Humans; NAD; Nicotinamide Mononucleotide; Obesity

2023
Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule.
    Biomolecules, 2019, 01-21, Volume: 9, Issue:1

    Topics: Alzheimer Disease; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; NAD; Nicotinamide Mononucleotide; Obesity

2019

Trials

2 trial(s) available for nicotinamide mononucleotide and Obesity

ArticleYear
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study.
    The Journal of clinical endocrinology and metabolism, 2023, Jul-14, Volume: 108, Issue:8

    Topics: Aged; Body Weight; Cholesterol; Humans; Insulin Resistance; Middle Aged; NAD; Nicotinamide Mononucleotide; Obesity; Overweight

2023
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
    Science (New York, N.Y.), 2021, 06-11, Volume: 372, Issue:6547

    Topics: Aged; Body Composition; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Overweight; Postmenopause; Prediabetic State; RNA-Seq; Signal Transduction

2021

Other Studies

6 other study(ies) available for nicotinamide mononucleotide and Obesity

ArticleYear
Administration of nicotinamide mononucleotide improves oocyte quality of obese mice.
    Cell proliferation, 2022, Volume: 55, Issue:11

    Topics: Actins; Animals; Diet, High-Fat; Female; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Obese; Nicotinamide Mononucleotide; Obesity; Oocytes; Pregnancy; Reactive Oxygen Species

2022
Declining muscle NAD
    Molecular metabolism, 2022, Volume: 65

    Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome

2022
Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet.
    IUBMB life, 2023, Volume: 75, Issue:6

    Topics: Animals; Body Composition; Diet, High-Fat; Metabolic Diseases; Mice; NAD; Nicotinamide Mononucleotide; Obesity; Sirtuins

2023
Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers.
    Cells, 2020, 03-25, Volume: 9, Issue:4

    Topics: Animals; Body Weight; Diet; Diet, High-Fat; Female; Gene Expression Regulation; Glucose Tolerance Test; Insulin; Liver; Male; Mice, Inbred C57BL; Mice, Obese; Nicotinamide Mononucleotide; Obesity; Organelle Biogenesis; Phenotype; Triglycerides; Weaning

2020
Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity.
    Atherosclerosis, 2014, Volume: 237, Issue:2

    Topics: Animals; Aorta; Apoptosis; Cattle; Cell Death; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Drug Combinations; Endothelial Cells; Gene Expression Regulation; Humans; Immunohistochemistry; Laminin; Lipids; Metabolic Syndrome; Microcirculation; NAD; Niacin; Nicotinamide Mononucleotide; Obesity; Protein Binding; Proteoglycans; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic; RNA Interference; RNA, Small Interfering; Serum Albumin

2014
NAMPT-Mediated NAD(+) Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in Mice.
    Cell reports, 2016, 08-16, Volume: 16, Issue:7

    Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Cyclin-Dependent Kinase 5; Cytokines; Fatty Acids, Nonesterified; Female; Gene Expression Regulation; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Knockout; Muscle, Skeletal; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Obesity; Phosphorylation; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones

2016